These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34531670)

  • 1. FOXA1 Suppresses SATB1 Transcription and Inactivates the Wnt/β-Catenin Pathway to Alleviate Diabetic Nephropathy in a Mouse Model.
    Zhu H; Peng J; Li W
    Diabetes Metab Syndr Obes; 2021; 14():3975-3987. PubMed ID: 34531670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 Promotes Mesangial Cell Proliferation and Kidney Fibrosis in Diabetic Nephropathy Through Activating STAT and β-Catenin Signal Pathway.
    Tao Y; Han J; Liu W; An L; Hu W; Wang N; Yu Y
    DNA Cell Biol; 2021 Oct; 40(10):1308-1316. PubMed ID: 34520253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA MEG3 suppresses podocyte injury in diabetic nephropathy by inactivating Wnt/β-catenin signaling.
    Che X; Deng X; Xie K; Wang Q; Yan J; Shao X; Ni Z; Ying L
    PeerJ; 2019; 7():e8016. PubMed ID: 31799068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trigonelline reverses high glucose-induced proliferation, fibrosis of mesangial cells via modulation of Wnt signaling pathway.
    Chen C; Shi Y; Ma J; Chen Z; Zhang M; Zhao Y
    Diabetol Metab Syndr; 2022 Feb; 14(1):28. PubMed ID: 35139912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide suppresses production of extracellular matrix proteins and ameliorates renal injury of diabetic nephropathy by enhancing Wnt/β-catenin signaling.
    Huang L; Lin T; Shi M; Chen X; Wu P
    Am J Physiol Renal Physiol; 2020 Sep; 319(3):F458-F468. PubMed ID: 32715762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knock-Down of Long Non-Coding RNA ANRIL Suppresses Mouse Mesangial Cell Proliferation, Fibrosis, Inflammation via Regulating Wnt/β-Catenin and MEK/ERK Pathways in Diabetic Nephropathy.
    Fang X; Hu J; Zhou H
    Exp Clin Endocrinol Diabetes; 2022 Jan; 130(1):30-36. PubMed ID: 32726814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells.
    Wang Q; Ren D; Li Y; Xu G
    Cell Cycle; 2019; 18(6-7):696-707. PubMed ID: 30784349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation.
    Zhang C; Zhu X; Li L; Ma T; Shi M; Yang Y; Fan Q
    Diabetes Metab Syndr Obes; 2019; 12():1297-1309. PubMed ID: 31447572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1.
    Liu DW; Zhang JH; Liu FX; Wang XT; Pan SK; Jiang DK; Zhao ZH; Liu ZS
    Exp Mol Med; 2019 Aug; 51(8):1-15. PubMed ID: 31371698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wnt Signaling Pathway in Diabetic Nephropathy.
    Wang H; Zhang R; Wu X; Chen Y; Ji W; Wang J; Zhang Y; Xia Y; Tang Y; Yuan J
    Front Cell Dev Biol; 2021; 9():701547. PubMed ID: 35059392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy.
    Tang W; Zhao Y; Zhang H; Peng Y; Rui Z
    BMC Nephrol; 2022 Mar; 23(1):124. PubMed ID: 35354439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.
    Shi M; Tian P; Liu Z; Zhang F; Zhang Y; Qu L; Liu X; Wang Y; Zhou X; Xiao Y; Guo B
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PC-1 NF suppresses high glucose-stimulated inflammation and extracellular matrix accumulation in glomerular mesangial cells via the Wnt/β-catenin signaling.
    Xiao L; Chen Y; Yuan Y; Xu B; Gao Q; Chen P; Zhang T; Guan T
    Exp Ther Med; 2019 Sep; 18(3):2029-2036. PubMed ID: 31410160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt signaling pathway.
    Lin CL; Cheng H; Tung CW; Huang WJ; Chang PJ; Yang JT; Wang JY
    Am J Nephrol; 2008; 28(2):290-7. PubMed ID: 18004065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Yuan LS; Du H; Ren QY; Yang RL; Liu SW; Liu SY; Shi KF; Wang B; Meng XF; Li TX; Zhang N
    Evid Based Complement Alternat Med; 2023; 2023():3357281. PubMed ID: 36760471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.